ECTRIMS and EBMT said stem cell transplant can be considered for some with RRMS, such as those who are younger and have less severe disease.

Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Multiple sclerosis (MS) is a progressive autoimmune disease that affects the brain and spinal cord, impacting 2.8 million ...

Formerly believed to predominantly affect Caucasians, new research indicates that MS actually may hit Blacks the hardest.

Many degenerative diseases, like Parkinson’s disease, multiple sclerosis, or heart failure, have always been concerning when it comes to ...

A groundbreaking study reveals that the drug LL-341070 could help repair myelin damage, offering hope for vision restoration ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

Inflammation is triggered by the immune system and is part of the body's natural response to injuries or disease. However, ...